When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EVOK - Evoke Pharma pops 8% after Gimoti listed in FDA Orange Book
Evoke Pharma Inc.
Evoke Pharma (EVOK) jumps 8.4% premarket in reaction to the announcement that its US patent No. 11,020,361 for Gimoti (metoclopramide) nasal spray is now listed in the FDA's “Orange Book”.The patent covers methods of use for nasal delivery of metoclopramide for the treatment of gastroparesis and carries a patent term to at least 2029. The FDA approved the NDA for Gimoti in June 2020.